Ferinject

Ferinject

Manufacturer:

Vifor Pharma

Distributor:

Vifor Pharma
Concise Prescribing Info
Contents
Ferric carboxymaltose
Indications/Uses
Fe deficiency when oral Fe prep are ineffective or cannot be used.
Dosage/Direction for Use
IV Individualized dosage. Max single dose: 1,000 mg/day. Can administer max of 1,000 mg once a wk.
Contraindications
Hypersensitivity. Anaemia not attributed to Fe deficiency. Evidence of Fe overload or disturbances in utilisation of Fe.
Special Precautions
Do not administer by SC or IM route. Closely monitor patients for signs & symptoms of hypersensitivity during & for at least 30 min following each administration. Stop treatment if hypersensitivity or signs of intolerance occur. Can cause transient & w/o clinical symptom hypophosphataemia. Patients w/ existing hypophosphatemia risk factors & prolonged high IV Fe-dose exposure. Patients w/ hepatic dysfunction. Acute or chronic infection, history of asthma, eczema or atopic allergies. Discontinue use in patients w/ ongoing bacteraemia. Stop immediately in case of paravenous leakage. Monitoring of Fe parameters eg, serum ferritin & transferrin saturation may assist in recognition of Fe accumulation. Pregnancy & lactation. Not recommended in childn <14 yr.
Adverse Reactions
Hypophosphataemia, headache, dizziness, flushing, HTN, nausea; inj/infusion site reactions. Potentially, anaphylactoid/anaphylactic reactions.
Drug Interactions
Concomitant use w/ oral Fe therapy (do not start oral Fe therapy for at least 5 days after the last administration of Ferinject).
ATC Classification
B03AC - Iron, parenteral preparations ; Used in the treatment of anemia
Presentation/Packing
Form
Ferinject soln for inj/infusion 500 mg/10 mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in